CEO: Rick E. Winningham

Sector: Healthcare
Industry:Biotechnology

Exchange: NASDAQ Global Market

Country: USA

Description: Theravance Biopharma Inc is a diversified biopharmaceutical company. It is engaged in discovery, research, development and commercialization of human therapeutics.


Key numbers

Market Capitalization:1012634080
Shares Outstanding: 56762000
Float: 38108701.274
Next Earning Date:2020-02-25
TTm EPS: -4.0045
TTm Dividend Rate:
200 days moving average:20.59
50 days moving average: 18.85
One day percent Change: 8.58



2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,